Category: Top Story

Seeing Machines Limited (LSE:SEE) delivered strong expansion in its automotive driver and occupant monitoring segment, with the number of vehicles on the road equipped with its technology rising 67% year on year to around 4.8 million. Quarterly production volumes increased 13% compared with the prior quarter and were up 117% from a year earlier.

Management expects royalty income to gather pace as European manufacturers step up installation of driver monitoring systems ahead of the EU’s 2026 General Safety Regulation requirements. The regulatory backdrop is reinforcing Seeing Machines’ role within next-generation vehicle safety systems.

The company also reported a sharp recovery in sales of its Guardian aftermarket solution for commercial fleets. Hardware units sold rose to 3,764 in the quarter, up from 368 previously, helping lift annual recurring revenue modestly to $14.0 million.

Chief executive Paul McGlone said the rebound in automotive production and Guardian volumes supports the company’s expectation of reaching positive adjusted EBITDA in the third quarter and across the second half of FY2026. This comes despite some delays in new requests for quotation (RFQs) and cumulative production volumes remaining below guaranteed thresholds.

While regulatory-driven growth and cost measures aimed at achieving cash-flow breakeven provide encouragement, the investment outlook remains constrained by ongoing losses and negative operating cash flow. Near-term technical indicators also point to weaker momentum, partially offset by improved sentiment following recent operational updates.

More about Seeing Machines

Seeing Machines is headquartered in Australia and listed on AIM. The company specialises in AI-powered computer vision systems that monitor driver and occupant behaviour to enhance transport safety.

Its technology is deployed by automotive manufacturers and commercial fleet operators, and is also applied in off-road and aviation settings, supporting safety and regulatory compliance across multiple transport sectors.

Barratt Redrow plc (LSE:BTRW) delivered a stable first-half performance despite subdued UK housing conditions. Total completions increased 4.7% to 7,444 homes, while adjusted operating profit remained broadly unchanged at £210.2 million. Adjusted profit before tax declined 13.6%, reflecting continued pressure on margins.

On a statutory basis, profit before tax rose to £156.2 million, supported by lower transaction and integration costs related to the Redrow acquisition. The group ended the period with net cash of £173.9 million, even after accounting for dividends and share buybacks, underlining the strength of its balance sheet.

Integration of the Redrow business is progressing in line with expectations. Cost synergies remain on track toward the £100 million target, driven by office consolidation, central function efficiencies and improved procurement terms. Revenue synergies are also advancing, particularly through planning initiatives across the enlarged land portfolio.

Barratt Redrow continues to highlight its leadership in build quality and sustainability standards. The forward order book stands at 11,168 homes, valued at £3.41 billion. For FY26, the company expects completions between 17,200 and 17,800 units and anticipates full-year adjusted profit before tax to align with current market consensus, dependent on the strength of the crucial spring selling season.

From an investment perspective, disciplined financial management and a robust balance sheet underpin the outlook, while the ongoing share repurchase programme enhances shareholder returns. However, profitability pressures, technical signals and valuation metrics suggest a degree of caution, with the shares appearing relatively expensive and lacking strong momentum.

More about Barratt Redrow

Barratt Redrow was formed through the combination of Barratt Developments and Redrow and is one of the UK’s leading housebuilders. The group operates across private and affordable housing markets, leveraging a substantial land bank and nationwide divisional structure to drive scale, efficiency and volume growth.

Its strategy emphasises build quality, customer satisfaction and sustainability, positioning the enlarged business to compete across a broad range of residential segments.

Severn Trent Plc (LSE:SVT) said it has made a solid start to the new regulatory cycle, with operational and environmental metrics progressing in line with internal targets and financial performance matching expectations. Supported by greater insourcing and the accelerated rollout of key programmes, the company now expects annual capital expenditure to reach the top of its previously guided £1.7 billion to £1.9 billion range — the largest investment commitment in its history.

The group forecasts at least £40 million in benefits this year from outcome delivery incentives and price control deliverables. It also anticipates securing a four-star rating under the Environmental Performance Assessment for the seventh year in a row, underlining its focus on environmental standards and service reliability.

Chief executive James Jesic said the investment programme is advancing well and reiterated the outlook provided at interim results. He also welcomed the Government’s recent water sector White Paper as a constructive development, noting that further regulatory clarity is expected later in the year.

From an investment standpoint, sentiment on recent earnings calls has been positive and technical indicators remain supportive. While the company’s balance sheet reflects relatively high leverage and negative free cash flow, overall trading performance remains resilient. Valuation levels appear reasonable, with an attractive dividend yield contributing to a steady investment case.

More about Severn Trent

Severn Trent is a UK-regulated provider of water and wastewater services, operating within Ofwat’s regulatory framework. Its returns and operational objectives are shaped by capital investment allowances, outcome delivery incentives and price control mechanisms, with a strategic emphasis on environmental performance and reliable service delivery for customers and communities.

BP Plc (LSE:BP.) saw its shares fall more than 4% after reporting a fourth-quarter loss of $3.4bn and announcing the suspension of its share buyback programme, marking a significant shift in capital allocation strategy. The result compares with a $1.2bn profit in the previous quarter and was driven by $4.3bn of adjusting items, largely impairments across the group’s gas and low-carbon businesses.

Underlying replacement cost profit, BP’s preferred earnings metric excluding one-off items, declined to $1.5bn from $2.2bn in the third quarter and came in below market expectations. For the full year 2025, underlying profit fell to $7.5bn from $8.9bn in 2024, reflecting a weaker oil price environment, a less favourable upstream mix and lower refinery throughput due to increased maintenance activity.

The group also took sizeable writedowns across its renewables portfolio, with impairments linked to solar, biogas and offshore wind assets contributing to total charges of more than $5bn for the year. These losses have added pressure on interim chief executive Carol Howle, who is moving to re-prioritise cash flow generation and balance-sheet repair ahead of incoming CEO Meg O’Neill’s arrival in April.

Howle said BP is taking “decisive action” to strengthen the business, pointing to the execution of a $20bn asset disposal programme and the decision to halt buybacks. Going forward, all surplus cash will be directed toward debt reduction, replacing earlier guidance that 30–40% of operating cash flow would be returned to shareholders. Net debt stood at around $22bn at year-end, supported by more than $3bn of divestment proceeds during the quarter.

Progress on portfolio simplification continued, with expected proceeds from completed and announced disposals now exceeding $11bn. A key transaction is the planned $6bn sale of a 65% stake in Castrol, after which BP will retain a 35% holding.

Operationally, the company reported record upstream plant reliability of 96.1% for 2025 and completed seven major projects during the year. Fourth-quarter upstream production averaged 2.34 million barrels of oil equivalent per day, slightly below the prior quarter but helped by a higher proportion of oil-weighted output. BP also highlighted encouraging exploration momentum, including the Bumerangue discovery offshore Brazil.

Despite the quarterly loss and buyback suspension, BP maintained its dividend at 8.32 cents per share and reaffirmed its commitment to annual dividend growth of at least 4%. Capital expenditure for 2026 will be set at the lower end of the $13–13.5bn guidance range, while the company increased its structural cost-reduction target to $5.5–6.5bn by the end of 2027.

Analysts acknowledged the strategic reset but cautioned that the move could leave BP lagging peers that continue to return higher levels of cash to shareholders. RBC Capital Markets reiterated its “sector perform” rating, describing the buyback suspension as appropriate given the balance-sheet position, while noting that BP now offers a materially lower distribution yield relative to competitors.

AstraZeneca PLC (LSE:AZN) said it expects sales and earnings to continue growing in 2026 after delivering fourth-quarter results broadly in line with market expectations. The drugmaker forecast that total revenue will increase at a mid- to high-single-digit rate at constant exchange rates next year, while core profit is expected to grow by a low double-digit percentage. The outlook was well received by investors, with the shares rising more than 1%.

For 2025, AstraZeneca reported revenue growth of 8% and an 11% increase in core profit, consistent with its prior guidance for high single-digit sales growth and low double-digit earnings expansion. In the fourth quarter ended 31 December, core earnings were $2.12 per share, while revenue rose 2% year on year to $15.50bn. Both figures were in line with company-compiled consensus forecasts. Core operating profit for the quarter totalled $4.10bn, below analyst expectations of $4.45bn.

Chief executive Pascal Soriot highlighted strong underlying momentum across the business, pointing to robust commercial execution and progress in the pipeline. During 2025, the company announced results from 16 positive Phase 3 trials and now has 16 blockbuster medicines in its portfolio. Oncology remained a key growth driver, with cancer drug sales rising 20% in the quarter to $7.03bn, while revenue from cardiovascular therapies fell 6% to $3.05bn, partly due to increased generic competition.

Analyst reaction was mixed but broadly constructive. Morgan Stanley described the results as “good enough,” noting that the midpoint of the new guidance implies around a 2% uplift to Street revenue expectations. However, the firm added that the implied 2026 operating margin could attract scrutiny, as assumed earnings growth of around 11% suggests a modest 1% downgrade to consensus EPS forecasts. Jefferies analyst Michael Leuchten said the 2026 outlook is likely to push consensus revenue estimates higher, while core earnings expectations are expected to remain broadly unchanged, despite a small headwind from higher net financing costs.

More about AstraZeneca PLC

AstraZeneca PLC is a global, science-led biopharmaceutical company focused on the discovery, development and commercialisation of prescription medicines. Its core therapy areas include oncology, cardiovascular, renal and metabolic diseases, respiratory and immunology, and rare diseases. Headquartered in the UK, the group operates worldwide and is one of the largest pharmaceutical companies listed on the London Stock Exchange.

Barclays PLC (LSE:BARC) has published its 2025 Annual Report alongside its Pillar 3 disclosures, with both documents made available via the National Storage Mechanism and the bank’s investor relations website. Shareholders who have elected to receive printed materials will also be sent a hard copy of the Annual Report, ensuring broad access to the information ahead of the group’s 2026 Annual General Meeting.

The reports provide detailed insight into Barclays’ financial position, risk management framework and governance arrangements for the year, supporting transparency and regulatory compliance. By formally filing the documents in line with disclosure guidance and listing requirements, the bank enables investors and other stakeholders to assess its performance and risk profile using comprehensive, up-to-date information.

From a market perspective, Barclays continues to be supported by strong underlying financial performance and ongoing strategic actions, including share buyback programmes. Technical indicators point to a constructive trend in the shares, while valuation metrics remain reasonable. Positive messaging from earnings updates and recent corporate developments further underpins confidence in the group’s outlook.

More about Barclays PLC

Barclays PLC is a global financial services group providing a broad range of banking and financial products. Its activities span retail and commercial banking, credit cards, corporate and investment banking, and wealth management, with a strong presence in the UK and international markets serving individuals, businesses and institutional clients.

Dunelm Group (LSE:DNLM) delivered a resilient first-half performance for the 26 weeks ended 27 December 2025, with total revenue rising 3.6% to £926.3m. Digital sales continued to increase as a proportion of the mix, reaching 41% of group revenue and helping Dunelm add 20 basis points of market share in the UK homewares and furniture market to 7.9%. Gross margin improved to 53.4%, supported by favourable foreign exchange movements while pricing to customers remained broadly unchanged. Despite lower profit before tax of £114m and some cost inflation, the board maintained a progressive capital return policy, increasing the interim ordinary dividend by 3% and declaring a special dividend.

The group acknowledged a tougher consumer environment and weaker trading in the second quarter, but pointed to a recovery in early third-quarter sales following a well-received Winter Sale and encouraging customer response to new spring product ranges. Newly appointed chief executive Clo Moriarty highlighted ongoing growth potential as the business prepares to launch a fully featured shopping app and works to rebuild furniture stock availability. Management reiterated guidance that full-year profit before tax is expected to be in line with current market forecasts, underscoring confidence in Dunelm’s operating model and strategic direction.

Overall, the investment outlook is supported by constructive technical signals and a valuation viewed as broadly reasonable. Trading performance remains solid, although this is tempered by elevated leverage levels and a slowdown in free cash flow growth.

More about Dunelm Group

Dunelm Group is the UK’s leading homewares retailer, offering over 100,000 products across homewares and furniture categories, including bedding, textiles, kitchenware, lighting, outdoor ranges and DIY. The group operates 203 stores across the UK and Ireland alongside a fast-growing online platform featuring home delivery, Click & Collect and in-store tablet ordering. Its ranges are predominantly own-brand and sourced from long-standing supplier relationships.

Founded in 1979 as a market stall in Leicester, Dunelm has grown into a nationwide retailer with Pausa coffee shops in most UK stores, around 12,500 employees and headquarters in Leicester. Listed on the London Stock Exchange since 2006, the company has returned more than £1.5bn to shareholders through a combination of ordinary and special dividends since its IPO.